Recombinant PDCD1 (Camrelizumab Biosimilar) antibody
This Mammalian Cells Monoclonal antibody specifically detects PDCD1 (Camrelizumab Biosimilar) in ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN7488116
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant PDCD1 (Camrelizumab Biosimilar) antibody (ABIN7488116)
Target
PDCD1 (Camrelizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This PDCD1 (Camrelizumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Camrelizumab Biosimilar - Anti-PDCD1, PD-1, CD279 mAb
-
Characteristics
- Antibody Type: IgG4-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG4 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- PDCD1 (Camrelizumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
SHR-1210
Camrelizumab is an IgG4κ humanized monoclonal antibody being investigated for hepatocellular carcinoma. It targets programmed cell death protein 1 (PD-1), a protein on the surface of cells, also known as CD279 (cluster of differentiation 279). -
CAS-No
- 1798286-48-2
Target
-
You are here:
